Guggenheim Assumes ORIC Pharmaceuticals (ORIC) at Buy
Tweet Send to a Friend
(Updated - September 4, 2025 5:42 AM EDT)
Guggenheim analyst Brad Canino assumes coverage on ORIC Pharmaceuticals (NASDAQ: ORIC) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Brad Canino assumes coverage on ORIC Pharmaceuticals (NASDAQ: ORIC) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


